|Articles|October 1, 2000

Supplements and Featured Publications

  • Antibody-Targeted Chemotherapy for the Treatment of Relapsed Acute Myeloid Leukemia
  • Volume 6
  • Issue 18 Suppl

Antibody-Targeted Chemotherapy for the Treatment of Relapsed Acute Myeloid Leukemia

Download PDF: Antibody-Targeted Chemotherapy for the Treatment of Relapsed Acute Myeloid Leukemia

Articles in this issue

over 25 years ago

Commentary: New Research and Treatment Options for Acute Myeloid Leukemia

over 25 years ago

Continuing Medical Education Quiz

over 25 years ago

Overview: Treatment of Acute Myeloid Leukemia

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!

Related Content

Latest CME

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs
Online Article

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

2.0 Credits / General Pharmacy

View more
Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care
AJMC Supplement

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

2.0 Credits / Pain Management

View more
Brand Logo

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences®

All rights reserved.

Secondary Brand Logo
Alt TextAlt Text